We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| GSK plc | NYSE:GSK | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.20 | 0.49% | 41.11 | 41.3125 | 40.87 | 40.95 | 2,730,464 | 01:00:00 |
From Apr 2019 to Apr 2024
--Hedge fund Elliott Management Corp. has amassed a multibillion-pound stake in British pharma company GlaxoSmithKline PLC, the Financial Times reports.
--Elliott's investment comes after shareholders' disappointment at the leadership of CEO Dame Emma Walmsley, who is breaking up the company starting next year by separating the consumer-health business and the vaccine division, according to the FT.
--GSK management is also being blamed for underperforming peers and lagging in the race to develop a Covid-19 vaccine, the FT reports.
--GSK shares are up 64.2 pence, or 5%, at 1,353.8 pence.
Full story: https://on.ft.com/3uK3MjU
Write to Barcelona editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
April 15, 2021 09:06 ET (13:06 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
